Steve Schonfeld’s AtriCure ATRC Stock Holding History

Steve Schonfeld’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Sell	68,243 -33,439	-33%	-$941K	0.01%	1090
2026 Q1	$2.9M	Buy	+101,682	New	+$3.47M	0.02%	673
2025 Q4	–	Sell	-12,022	Closed	-$424K	–	2049
2025 Q3	$424K	Buy	+12,022	New	+$414K	﹤0.01%	1729
2024 Q2	–	Sell	-30,298	Closed	-$922K	–	2142
2024 Q1	$922K	Buy	30,298 +22,750	+301%	+$762K	0.01%	1260
2023 Q4	$269K	Buy	+7,548	New	+$281K	﹤0.01%	1459
2022 Q3	–	Sell	-10,048	Closed	-$411K	–	2938
2022 Q2	$411K	Buy	+10,048	New	+$476K	﹤0.01%	1470
2022 Q1	–	Sell	-13,539	Closed	-$941K	–	2581
2021 Q4	$941K	Buy	+13,539	New	+$984K	0.01%	974
2021 Q3	–	Sell	-7,900	Closed	-$627K	–	2148
2021 Q2	$627K	Buy	+7,900	New	+$574K	0.01%	1088

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Steve Schonfeld's ATRC Position: Q2 2026 in Review

Steve Schonfeld reduced its AtriCure (ATRC) stake by 33% in Q2 2026, selling an estimated $941K and leaving 68,243 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #1090.

Steve Schonfeld first reported a position in ATRC in Q2 2021 and has held it in 8 quarters since. The position peaked at $2.9M in Q1 2026. 250 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

Steve Schonfeld held 68,243 shares of AtriCure worth $1.91M as of Q2 2026.
Steve Schonfeld sold 33,439 AtriCure shares in Q2 2026, an estimated $941K.
AtriCure made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #1090 holding.
Steve Schonfeld first reported a position in AtriCure in Q2 2021 and has held it in 8 quarters since.
Steve Schonfeld's AtriCure position peaked at $2.9M in Q1 2026.
250 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.